Enoxacin (Parke-Davis)

Gespeichert in:
Bibliographische Detailangaben
Format: Buch
Sprache:German
English
Veröffentlicht: München MMV, Medizin-Verl. 1986
Schriftenreihe:Infection Supplement ; 14,3
Schlagworte:
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

MARC

LEADER 00000nam a2200000 cb4500
001 BV008082980
003 DE-604
005 20040315
007 t|
008 930712s1986 xx d||| |||| 00||| ger d
035 |a (OCoLC)14235388 
035 |a (DE-599)BVBBV008082980 
040 |a DE-604  |b ger  |e rakwb 
041 0 |a ger  |a eng 
049 |a DE-20  |a DE-19 
245 1 0 |a Enoxacin (Parke-Davis) 
264 1 |a München  |b MMV, Medizin-Verl.  |c 1986 
300 |a S. 181 - 220  |b graph. Darst. 
336 |b txt  |2 rdacontent 
337 |b n  |2 rdamedia 
338 |b nc  |2 rdacarrier 
490 1 |a Infection : Supplement  |v 14,3 
500 |a Beitr. teilw. dt., teilw. engl. - Zsfassungen in dt. und engl. Sprache 
650 4 |a Bacterial Infections  |x drug therapy 
650 4 |a Naphthyridines  |x pharmacology 
650 4 |a Naphthyridines  |x therapeutic use 
650 4 |a Quinolines  |x pharmacology 
650 4 |a Urinary Tract Infections  |x drug therapy 
830 0 |a Infection  |v Supplement ; 14,3  |w (DE-604)BV004443225  |9 14,3 
943 1 |a oai:aleph.bib-bvb.de:BVB01-005322309 

Datensatz im Suchindex

_version_ 1819234883213459457
any_adam_object
building Verbundindex
bvnumber BV008082980
ctrlnum (OCoLC)14235388
(DE-599)BVBBV008082980
format Book
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01048nam a2200325 cb4500</leader><controlfield tag="001">BV008082980</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20040315 </controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">930712s1986 xx d||| |||| 00||| ger d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)14235388</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV008082980</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">ger</subfield><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-20</subfield><subfield code="a">DE-19</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Enoxacin (Parke-Davis)</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">München</subfield><subfield code="b">MMV, Medizin-Verl.</subfield><subfield code="c">1986</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">S. 181 - 220</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Infection : Supplement</subfield><subfield code="v">14,3</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Beitr. teilw. dt., teilw. engl. - Zsfassungen in dt. und engl. Sprache</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Bacterial Infections</subfield><subfield code="x">drug therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Naphthyridines</subfield><subfield code="x">pharmacology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Naphthyridines</subfield><subfield code="x">therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Quinolines</subfield><subfield code="x">pharmacology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Urinary Tract Infections</subfield><subfield code="x">drug therapy</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Infection</subfield><subfield code="v">Supplement ; 14,3</subfield><subfield code="w">(DE-604)BV004443225</subfield><subfield code="9">14,3</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-005322309</subfield></datafield></record></collection>
id DE-604.BV008082980
illustrated Illustrated
indexdate 2024-12-23T12:39:43Z
institution BVB
language German
English
oai_aleph_id oai:aleph.bib-bvb.de:BVB01-005322309
oclc_num 14235388
open_access_boolean
owner DE-20
DE-19
DE-BY-UBM
owner_facet DE-20
DE-19
DE-BY-UBM
physical S. 181 - 220 graph. Darst.
publishDate 1986
publishDateSearch 1986
publishDateSort 1986
publisher MMV, Medizin-Verl.
record_format marc
series Infection
series2 Infection : Supplement
spelling Enoxacin (Parke-Davis)
München MMV, Medizin-Verl. 1986
S. 181 - 220 graph. Darst.
txt rdacontent
n rdamedia
nc rdacarrier
Infection : Supplement 14,3
Beitr. teilw. dt., teilw. engl. - Zsfassungen in dt. und engl. Sprache
Bacterial Infections drug therapy
Naphthyridines pharmacology
Naphthyridines therapeutic use
Quinolines pharmacology
Urinary Tract Infections drug therapy
Infection Supplement ; 14,3 (DE-604)BV004443225 14,3
spellingShingle Enoxacin (Parke-Davis)
Infection
Bacterial Infections drug therapy
Naphthyridines pharmacology
Naphthyridines therapeutic use
Quinolines pharmacology
Urinary Tract Infections drug therapy
title Enoxacin (Parke-Davis)
title_auth Enoxacin (Parke-Davis)
title_exact_search Enoxacin (Parke-Davis)
title_full Enoxacin (Parke-Davis)
title_fullStr Enoxacin (Parke-Davis)
title_full_unstemmed Enoxacin (Parke-Davis)
title_short Enoxacin (Parke-Davis)
title_sort enoxacin parke davis
topic Bacterial Infections drug therapy
Naphthyridines pharmacology
Naphthyridines therapeutic use
Quinolines pharmacology
Urinary Tract Infections drug therapy
topic_facet Bacterial Infections drug therapy
Naphthyridines pharmacology
Naphthyridines therapeutic use
Quinolines pharmacology
Urinary Tract Infections drug therapy
volume_link (DE-604)BV004443225